Sysmex Chile SpA
Basic information
- Head office
- 1-5-1 Wakihama Kaigan-dori, Chuo-ku, Kobe-shi, Hyogo-ken 651-0073
- Chief executive
- Ishine Matsui
- Capital
- 14,887,000,000 JPY (148 100 millionJPY)
- Employees (non-consolidated)
- 3,400 people
- Employees (consolidated)
- 11,457 people
- Start date
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
Network
History
Taro Nakata departs for overseas inspection, having sought a new business pillar while at TOA Corporation (formerly TOA Special Electric Co., Ltd.), a leading manufacturer of amplification devices![]()
TOA Special Electric Co., Ltd. (now TOA Corporation) decides to enter the medical electronic device industry, establishes a new laboratory, and three engineers begin research![]()
CC-1001 successfully commercializes Japan’s first automatic blood cell counter (Automatic Blood Cell Counter CC-1001)![]()
MCC News Issue 1: Launch of Automatic Blood Cell Counter CC-1002; MCC News is distributed to hospital laboratories nationwide (MCC: Micro Cell Counter)![]()
First diagnostic reagent developed: dilution solution "Cell Kit" and hemolysin "Saponin-S"; released as the first diagnostic reagents by an electrical manufacturer![]()
At the time, the ME Equipment Department of TOA Special Electric Co., Ltd. (now TOA Corporation) is established (ME = Medical Electronics)![]()
Basic Management Policy "Three Assurances" (current founding philosophy); establishes "Basic Principles of Company Management" summarizing fundamental management concepts and action guidelines![]()
TOA Medical Electronics Co., Ltd. is founded as a sales company for medical electronic devices manufactured by TOA Special Electric Co., Ltd. (now Sysmex Corporation)![]()
Cell Check-B: releases standard material "Cell Check™-B" containing specific cell counts to verify accurate blood cell measurement in laboratories![]()
German Representative Office (Hamburg): acquires the medical electronic device development and manufacturing division of TOA Special Electric Co., Ltd. (now TOA Corporation) and establishes a new clinical laboratory equipment manufacturer; first overseas branch in Germany![]()
Kakogawa Factory (Kakogawa City, Hyogo Prefecture): establishes Kakogawa Factory in Kakogawa City, Hyogo Prefecture, consolidating sales, development, production, and general affairs departments![]()
Taro Nakaya’s passionate speech at the founding anniversary ceremony deeply resonated within the company, as he strongly instructed all employees that "quality is heart. It is the life of the company."![]()
Released the CC-710, Japan’s first fully automatic hematology analyzer (Fully Automatic Hematology Analyzer CC-710).![]()
Established an overseas office in the United States (San Francisco), marking the start of entry into the U.S. market.![]()
Released the CC-720, the world’s first fully automatic hematology analyzer equipped with an automatic sample feeder (sampler).![]()
Establishment of local subsidiary in Europe (Hamburg, Germany) – TOA MEDICAL ELECTRONICS (DEUTSCHLAND) GMBH (now Sysmex Europe SE)![]()
Establishment of the European subsidiary Toa Medical Electronics (Deutschland) GmbH (now Sysmex Europe SE)![]()
Released the E Series, a multi-parameter automatic hematology analyzer that established the "Sysmex" brand overseas.![]()
Released the CA-3000 Automatic Coagulation Analyzer, incorporating robotic engineering ideals to achieve random processing for each sample.![]()
Strengthening development structure in blood coagulation, immunology, and urinalysis – New Kobe factory at Nishinaga Industrial Park, research & development moved (Hyogo Prefecture, Kobe City / now Techno Park)![]()
Established a new Kobe factory in the Nishin Industrial Complex (Nishi-ku, Kobe) and relocated the R&D department (now Techno Park).![]()
Released the PAMIA-10 Immunoagglutination Analyzer, measuring trace proteins in serum using a proprietary immunoassay, entering the immunology field.![]()
Rei-zo Hashimoto appointed president – declared "world leadership in hematology within 10 years" and "new business revenue share over 40%"![]()
Declared "to become a world leader in hematology within 10 years" and "to achieve a new business revenue composition ratio of over 40%".![]()
Released the R-1000 Automatic Reticulocyte Analyzer, the world’s first device capable of automatically measuring reticulocytes.![]()
Released the NE-8000 Multi-Parameter Automatic Hematology Analyzer, enabling simultaneous measurement of hematology counts and leukocyte differential, with comprehensive biohazard precautions.![]()
Moved headquarters to Chuo-ku, Kobe (Port Island), consolidating headquarters functions and sales & trade departments.![]()
Released the HS Series Comprehensive Hematology Test System, the world’s first fully automated system covering hematology counts, leukocyte differential, reticulocyte counts, and slide preparation.![]()
Released the UA-1000 Automatic Urine Analyzer, entering the urine sediment analysis field with an in-house developed product.![]()
First domestic diagnostic drug production plant established (Kōno City, Hyogo Prefecture); first overseas direct sales, service & support launched (UK) – establishment of first overseas sales subsidiary TOA MEDICAL ELECTRONICS (UK) LTD. (now Sysmex UK Limited)![]()
Established the Ono plant in Ono City, Hyogo Prefecture as the first domestic diagnostic drug production facility, relocating the diagnostic drug production division![]()
Commenced diagnostic drug production overseas (Germany); established European production site in Nuremberg; established U.S. production site SYSMEX CORPORATION OF AMERICA (now Sysmex Reagents America, Inc.)![]()
Accelerated expansion in blood coagulation testing – entered into sales partnership with Deid International (now Siemens Healthineers Diagnostics Co., Ltd.) for blood coagulation products; established supply & technical service system in China; founded joint venture Jiangnan Donghua Medical Electronics Co., Ltd. (now Jiangnan Hoshin Medical Electronics Co., Ltd.) in Jiangnan, China![]()
Listed on Osaka Stock Exchange Second Section; strengthened corporate structure through listing activities – later listed on Tokyo Stock Exchange Second Section (1996) and promoted to First Section of Osaka and Tokyo Stock Exchanges (2000)![]()
Established the German subsidiary Sysmex GmbH Deutschland (now Sysmex Deutschland GmbH) and entered into a business alliance with Dieid International (now Siemens Healthineers Diagnostics Ltd.) for the sale of coagulation products![]()
Held a press conference for the establishment of Zhennan Hishin Medical Electronics Co., Ltd. and set up a joint venture in China, Zhennan Dongya Medical Electronics Co., Ltd. (now Zhennan Hishin Medical Electronics Co., Ltd.)![]()
Released the SF-3000, a multi-parameter automated hematology analyzer that integrates semiconductor laser and flow cytometry technology, promoting the spread of white blood cell differential analyzers in small to medium-sized laboratories![]()
Released the UF-100, the world's first fully automated urinary sediment analyzer, and listed on the second section of the Osaka Stock Exchange![]()
Kazuhiko Ieji (now Chairman & Group CEO) appointed president – declared "aiming to become a distinctive global integrated manufacturer from a specialty maker"![]()
Listed on the second section of the Tokyo Stock Exchange; Chairman Kaji Kose (now Group CEO) became president and declared a shift from a specialty manufacturer to a globally distinctive integrated manufacturer![]()
Established Asia-Pacific regional headquarters SYSMEX SINGAPORE PTE LTD. (now Sysmex Asia Pacific Pte Ltd.) – strengthened global sales network through partnership with F. Hoffmann-La Roche (Switzerland) for hematology products; began diagnostic drug production in India – founded joint venture SYSMEX TRANSASIA BIO-MEDICALS PRIVATE LTD. (now Sysmex India Pvt. Ltd.) – renamed company to Sysmex Corporation on 30th anniversary and relocated headquarters![]()
Established Sysmex Singapore Pte Ltd. (now Sysmex Asia Pacific Pte Ltd.) as the regional headquarters for the Asia-Pacific area![]()
Entered a basic agreement for a global business alliance with F. Hoffmann-La Roche AG (Switzerland) for sales cooperation and joint R&D![]()
Established the joint venture Sysmex Transasia Bio-Medicals Private Ltd. (now Sysmex India Pvt. Ltd.) in India for equipment and diagnostic drug production, obtaining ISO 13485 and EN 46001 certifications![]()
Renamed the headquarters to Sysmex Corporation (Hyogo Prefecture, Kobe City, Chuo Ward) and moved it to the eastern part of Kobe's new city center![]()
Released the XE-2100, a multi-parameter automated hematology analyzer, achieving labor-saving and efficiency improvements in laboratory operations![]()
Released "XE-2100" multi-parameter automated hematology analyzer – realized labor-saving and efficiency in testing operations![]()
Establishment of customer support center in Hong Kong, local subsidiary Hoshin Meikang Hong Kong Ltd.![]()
Sysmex Shanghai Ltd. (Sysmex Medical Electronics (Shanghai) Co., Ltd.) Chinese local subsidiary Sysmex Medical Electronics (Shanghai) Co., Ltd. established![]()
Established China regional headquarters Sysmex Shanghai Ltd. (Hoshin Medical Electronics (Shanghai) Co., Ltd.) – expanded global production system for stable diagnostic drug supply; began diagnostic drug production in Brazil and Singapore; started challenge in life science field – established central research institute within Techno Center (now Techno Park) in Kobe, Hyogo Prefecture![]()
Launch of PAMIA-40i, an immunoagglutination analyzer that reduces whole blood test time to about one-third![]()
Capital participation in Delphic Medical Systems, renaming to Sysmex Delphic Limited (now Sysmex New Zealand Limited)![]()
Strengthened R&D for bio-diagnostic drug production – fully acquired International Reagents Co., Ltd. (absorbed in 2022)![]()
Development of a genetic test that detects the presence of cancer cell metastasis to lymph nodes within 15 minutes![]()
Launch of direct sales and services in the United States; integration of Sysmex Corporation of America and Sysmex Infosystems America, Inc. to form Sysmex America, Inc.![]()
Chinese local subsidiary Sysmex Biotech (Wuxi) Co., Ltd. (Diagnostic Drug Second Factory) established![]()
Acquisition of CNA Co., Ltd. (now Sysmex CNA Co., Ltd.); technology for measuring embryonic stem cells receives Special Award at the 2004 National Invention Awards![]()
Establishment of Sysmex BMA Laboratory in Port Island, Kobe City, as part of the medical industry city initiative![]()
Launch of high-performance, compact multi-parameter automated hematology analyzer XS Series, following the measurement principles of the XE Series![]()
Enabled rapid intraoperative lymph node metastasis testing for breast, colorectal, and gastric cancers, contributing to patient QOL improvement – first life science product "RD-100i" gene amplification detection system and related diagnostic drug "RinoAmp™BC" launched in Europe![]()
Released "HISCL™-2000i" fully automated immunoassay analyzer, achieving high-sensitivity rapid testing with minimal sample volume through CLEIA (chemiluminescent enzyme immunoassay) development![]()
Celebrating its 40th anniversary, the company unveiled a new corporate logo and opened the Core Research & Development Hub, Techno Park, in Kobe City, Hyogo Prefecture, with the concept "Creating and inheriting knowledge."![]()
Aiming to establish its position as the absolute global leader in hematology, the company globally launched the flagship model "Multi-parameter Automatic Blood Cell Analyzer XN™ Series" in the blood cell counting field, and released the new model "Fully Automatic Coagulation Analyzer CS-5100™" in the blood coagulation testing field, which improves processing capacity.![]()
Technology for leukocyte differential counting method and diagnostic reagents received the 2011 National Innovation Award (Innovation Prize) in Japan![]()
Clinical testing system applying the design concept "Silent Design™" received the 2011 Good Design Gold Award![]()
With a rapid 17-minute measurement and evolved functionality, the company contributed to test efficiency and the realization of pre-treatment testing by launching the new model "Fully Automatic Immunoassay Analyzer HISCL™-5000" in the immunohematology field.![]()
Entering the medical robotics market, the company co-founded a marketing firm for medical robot development with Kawasaki Heavy Industries, Ltd. and MedicaRoid Co., Ltd., accelerating the expansion of a technology platform for personalized medicine. It acquired the German company Partec GmbH (now Sysmex Partec GmbH), a pioneer in FCM technology, and the German company Inostics GmbH (now Sysmex Inostics GmbH), which has technology for highly sensitive measurement of cancer genes in blood.![]()
"Development of a particle classification counting method in a multi-parameter automated hematology analyzer" received the Minister of Education, Culture, Sports, Science and Technology Award for Fiscal Year 2013![]()
Joint establishment of Kawasaki Heavy Industries Co., Ltd. and Medicaid Co., Ltd. for medical robot development![]()
Successful development of the first practical liver fibrosis test using a glycoconjugate marker "HISCL™ M2BPGi™ diagnostic reagent"![]()
Entering the contract genetic testing business, the company invested in RIKEN Genesis Co., Ltd. to advance the genetic testing industry (acquired as a subsidiary in 2016).![]()
"Development of a urine sample analysis method useful for early disease detection" received the 2024 Minister of Education, Culture, Sports, Science and Technology Award for Science and Technology![]()
"Rapid Antimicrobial Susceptibility Testing System PA-100 AST System" received the UK’s largest science award "Longitude Prize on AMR"![]()
News
There is no news.